Skip to main content

Table 2 Univariable and multivariable cox regression models predicting intravesical RFS and Overall RFS of 265 patients with UTUC after radical nephroureterectomy

From: Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study

Variable

Intravesical

RFS

Overall

RFS

 

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

 

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

Age, continuous

0.99 (0.96–1.01)

0.359

0.98 (0.96–1.01)

0.239

1.00 (0.99–1.01)

0.981

0.99 (0.97–1.01)

0.232

Gender

 Male

1

0.181

1

0.07

1

0.94

1

0.258

 Female

0.59 (0.28–1.3)

 

0.45 (0.19–1.07)

 

1.02 (0.69–1.50)

 

0.77 (0.48–1.22)

 

Smoking

 No

1

0.273

1

0.357

1

0.021

1

0.057

 Yes

1.41 (0.76–2.58)

 

1.41 (0.68–2.89)

 

1.54 (0.07–2.22)

 

1.52 (0.99–2.33)

 

Previous hydronephrosis

 No

1

0.768

1

0.269

1

0.08

1

0.83

 Yes

1.10 (0.59–2.03)

 

0.65 (0.30–1.40)

 

1.41 (0.96–2.08)

 

0.94 (0.56–1.59)

 

Previous bladder urothelial carcinoma

 No

1

0.394

1

0.491

1

0.8

1

0.291

 Yes

1.56 (0.56–4.7)

 

0.65 (0.19–2.24)

 

1.10 (0.52–2.37)

 

1.60 (0.67–3.84)

 

Concomitant bladder urothelial carcinoma

 No

1

0.048

1

0.014

1

0.369

1

0.585

 Yes

1.95 (1.01–3.76)

 

2.71 (1.22–5.99)

 

1.23 (1.79–1.91)

 

1.15 (0.70–1.89)

 

Laterality

 Left

1

0.276

1

0.573

1

0.789

1

0.534

 Right

1.38 (0.77–2.48)

 

1.20 (0.64–2.24)

 

0.95 (0.68–1.35)

 

1.13 (0.78–1.64)

 

Tumor location

 Renal pelvis

1

0.093

1

0.129

1

0.001

1

0.003

 Ureter

1.67 (0.89–3.17)

 

1.57 (0.65–3.78)

 

1.25 (0.86–1.80)

 

1.60 (0.96–2.67)

 

 Renal pelvis and ureter

2.82 (1.02–7.78)

 

3.72 (1.04–13.25)

 

3.15 (1.74–5.71)

 

3.52 (1.70–7.26)

 

Tumor size, continuous

0.90 (0.76–1.06)

0.209

0.91 (0.74–1.11)

0.353

1.07 (0.98–1.17)

0.112

1.02 (0.92–1.13)

0.682

Tumor focality

 Unifocal

1

0.608

1

0.757

1

0.015

1

0.492

 Multifocal

1.17 (0.65–2.09)

 

1.12 (0.56–2.23)

 

1.54 (1.09–2.17)

 

1.15 (0.77–1.72)

 

LVI

 No

1

0.582

1

0.746

1

< 0.001

1

< 0.001

 Yes

0.83 (0.42–1.63)

 

0.89 (0.43–1.83)

 

2.20 (1.54–3.13)

 

2.03 (1.39–2.96)

 

Tumor grade

 Low

1

0.91

1

0.525

1

< 0.001

1

< 0.001

 High

0.97 (0.54–1.74)

 

0.79 (0.39–1.62)

 

3.72 (2.41–5.73)

 

2.47 (1.51–4.03)

 

pT stage

 pT1

1

0.434

1

0.471

1

< 0.001

1

< 0.001

 pT2

1.48 (0.70–3.10)

 

1.18 (0.52–2.67)

 

1.54 (0.86–2.76)

 

1.72 (1.06–3.03)

 

 pT3/pT4

0.96 (0.48–1.93)

 

1.67 (0.73–3.78)

 

3.46 (2.18–5.50)

 

2.57 (1.47–4.48)

 

pN stage

 pN0

1

0.097

1

0.308

1

0.489

1

0.677

 pNx

1.73 (0.91–3.28)

 

1.45 (0.71–2.94)

 

1.13 (0.79–1.62)

 

1.09 (0.74–1.61)

 

Distal ureter management

 Extravesical

1

< 0.001

1

< 0.001

1

0.011

1

0.129

 Open intravesical

0.32 (0.18–0.59)

 

0.25 (0.13–0.50)

 

0.63 (0.43–0.94)

 

0.73 (0.47–1.12)

 

 Endoscopic

0.17 (0.06–0.49)

 

0.11 (0.03–0.42)

 

0.46 (0.27–0.79)

 

0.52 (0.27–1.01)

 

Adjuvant chemotherapy

 No

1

0.043

1

0.033

1

0.035

1

0.194

 Yes

0.35 (0.12–0.97)

 

0.28 (0.09–0.90)

 

1.52 (1.03–2.26)

 

0.74 (0.46–1.17)

 

Type of procedure

 ONU

1

0.211

1

0.622

1

0.082

1

0.974

 LNU

0.58 (0.25–1.34)

 

1.23 (0.46–3.65)

 

0.66 (0.41–1.06)

 

0.99 (0.54–1.83)

 
  1. Bold values indicate that P-value ≤ 0.05, and considered statistically significant. ONU open radical nephroureterectomy, LNU laparoscopic radical nephroureterectomy, UTUC upper tract urothelial carcinoma, LVI lymphovascular invasion, RFS recurrence-free survival, OR odds ratio, CI confidence interval